Table 2.
Prognostic factor | PFS (days) | p-value |
---|---|---|
Tumor volume, 20 mL | 0.955 | |
≤20 mL | 239±32 | |
>20 mL | 230±32 | |
Tumor volume, 15 mL | 0.247 | |
≤15 mL | 199±3 | |
>15 mL | 239±37 | |
50% isodose volume | 0.839 | |
≤18.8 mL | 230±29 | |
>18.8 mL | 239±36 | |
70% isodose volume | 0.622 | |
≤7.5 mL | 238±48 | |
>7.5 mL | 235±26 | |
80% isodose volume | 0.846 | |
≤3.3 mL | 239±7 | |
>3.3 mL | 197±32 | |
Peri-GKRS systemic treatment | 0.741 | |
Yes | 239±50 | |
No | 230±29 | |
Previous brain irradiation | 0.019 | |
Yes | 85±55 | |
No | 238±4 | |
Lung cancer primary | 0.041 | |
Yes | 435±153 | |
No | 230±28 |
PFS : progression free survival, GKRS : Gamma Knife radiosurgery